HHS Awards $2.25 Million to 19 Phase 1 Winners of Caregiver AI Challenge for Tools to Strengthen Care
-
By
-
Assistant Secretary for Public Affairs (ASPA)
-
November 18, 2026
By
Assistant Secretary for Public Affairs (ASPA)
November 18, 2026
by Assistant Secretary for Public Affairs (ASPA)
November 18, 2026
The FDA approved the oral therapy after a 52-week trial showed improvement in neurological assessments.
by Teraya Smith
November 18, 2026
Median survival reached 8.5 vs 4.9 years in patients with infantile-onset Niemann-Pick disease type C.
by Mouj Hijazi
November 18, 2026
Beyond muscle jerks, episodes involved sensory symptoms, emotional distress, and difficulty returning to sleep.
November 18, 2026